Background: Major Depressive Disorder (MDD) is a clinically heterogeneous disorder. Previous 27
Introduction 54
Clinical depression is a markedly complex and debilitating mental disorder characterised 55 by sad, irritable or empty mood, diminished pleasure, and cognitive and somatic impairment 1 . 56
The heritability of major depressive disorder (MDD) is estimated to be ~37% from twin studies 2 
57
with common Single Nucleotide Polymorphisms (SNPs) explaining around 9% of the variation 58 in liability 3 . MDD has substantial comorbidity with other psychiatric and substance use disorders 59
and is related to a wide range of personality, socioeconomic, and human traits 4 . There is 60 substantial overlap in the genetic risk factors of MDD and other psychiatric disorders 3 , including 61 significant genetic correlations (rg) with schizophrenia (rg = 0.34), bipolar disorder (rg = 0.32), 62 autism spectrum disorders (rg = 0.44) and ADHD (rg = 0.42). MDD has notably high genetic 63 overlap with anxiety disorders (rg = 0.80) and neuroticism (rg = 0.70), which may reflect the 64 overlap in diagnostic criteria between the three traits. Initial efforts to identify genetic variants 65 associated with major depression were unsuccessful, despite successes with other psychiatric 66 diseases and traits. While a Genome Wide Association Study (GWAS) of schizophrenia (9,394 67 cases), for example, detected seven genome-wide significant associations 5 , a mega-analysis of 68 MDD (9240 cases) 6 and a meta-analysis of depressive symptoms (N = 34,549) 7 found no 69 significant associations. By 2014, 108 independent genetic loci for schizophrenia had been 70 identified 8 , and not a single one for depression. The struggle to identify significant genetic 71 variants was likely related to low statistical power due to the clinical heterogeneity of MDD 9 . 72
Depression is a polygenic disorder, influenced by the combination of small effects from 73 many genetic variants which can only be detected in studies with large sample sizes 10 . Due to the 74 relatively high prevalence of depression (~15% vs. <1% for schizophrenia), power is lower than 75 for other diseases with similar numbers of cases but lower prevalence 11 . Also, depression is less 76 heritable than other psychiatric disorders (~37% vs. ~80% for schizophrenia 12 ) and therefore 77 larger sample sizes are required to obtain similar statistical power to detect significant effects. In 78 the last two yours, increasing sample size has proved to be effective with the number of genome-79 wide significant variants increasing steadily with sample size. Hyde, et al. 13 identified 15 80 genome-wide significant loci associated with self-reported depression (N = 307,354). Another 17 81 loci were identified across three broad depression phenotypes (N = 322,580) 14 . The largest 82 GWAS of major depression to date (N = 480,359) identified 44 significant loci 3 . 83
These genetic studies ignored possible clinical heterogeneity in MDD, despite clinical 84 presentations and symptoms of MDD being diverse. The Diagnostic and Statistical Manual of 85
Mental Disorders 5th edition (DSM-5) defines major depression by the following symptoms: (1) 86 depressed mood, (2) diminished interest or pleasure in activities (anhedonia), (3) decrease or 87 increase in weight or appetite, (4) insomnia or hypersomnia, (5) psychomotor agitation or 88 retardation, (6) fatigue or loss of energy, (7) feelings of worthlessness or excessive or 89 inappropriate guilt, (8) diminished ability to think or concentrate, or indecisiveness, and (9) 90 recurrent thoughts of death or recurrent suicidal ideation 15 . For a diagnosis of MDD five or more 91 of these symptoms need to be present during a two week period, with at least one symptom being 92 depressed mood or anhedonia. Østergaard, et al. 16 18 . Further, the diagnostic criteria of MDD were found 104 to reflect three underlying genetic factors (cognitive / psychomotor symptoms, mood symptoms, 105 and neurovegetative symptoms) rather than a single factor of genetic risk in a twin study 19 . 106
Nagel, et al. 20 found substantial genetic heterogeneity in neuroticism, a personality trait with 107 extensive phenotypic and genetic overlap with MDD 21 , by conducting genetic analyses on the 108 individual items used to measure neuroticism. 109
To date, it is not known to what extent genetic risk factors overlap in individual 110 symptoms of MDD. The aim of the present study is to examine and assess the extent of genetic 111 heterogeneity in major depression. We conduct genetic analyses on individual symptoms of 112 depression in 148,752 participants within the UK Biobank, as measured by the nine items of the 113
Patient Health Questionnaire (PHQ-9) 22 , a depression measure which directly maps onto the 114 DSM-5 criteria. In order to examine genetic heterogeneity in depression we (1) 
Sample selection 128
First, participants were included in the present study if they were of white British 129 ancestry, identified through self-reported ethnicity and genetic principal components. 130
Participants who self-reported as not white British, but for whom the first two genetic principal 131 components indicated them to be genetically similar to those of white British ancestry were also 132 included in order to maximise sample size (these commonly were participants who reported to be 133 of Irish ancestry). Second, Participants were excluded if they were identified with schizophrenia 134 and / or other psychotic disorders, bipolar disorder, cyclothymic disorder, or dissociative identity 135 disorder, based on self-reported symptoms or diagnosis, reported prescription of an antipsychotic 136 medication, and/or ICD-10 (The International Classification of Diseases, Tenth Revision) codes 137 from linked hospital admission records. Third, only participants who provided a response for all 138 nine items of the PHQ-9 were included (list-wise deletion represented a less than 2% reduction 139 in sample size). This resulted in a final sample size of 148,752 (see Supplementary Figure 13 for 140 flow diagram of sample selection). 141
PHQ-9 142
The PHQ-9 is a commonly used self-administered measure of depression containing nine 143 items that map directly onto the nine DSM diagnostic criteria for major depression 22 . Each PHQ-144 9 item assesses the frequency of that symptom over the past two weeks, rated on a four-point 145 ordinal scale: (0) Not at all, (1) Several days, (2) More than half the days, (3) Nearly every day. 146 (See Supplementary Table 1 for the nine symptoms of major depression, PHQ-9 items, and 147
DSM-5 diagnostic criteria). 148
The PHQ-9 is a psychometrically valid and reliable measure of depression 24 . Test-retest 149 reliability was high (r = .84, over a span of 48 hours) and internal consistency was excellent with 150
Cronbach's alphas (α) of .89 and .86 in primary care and obstetrics-gynaecology samples, 151
respectively. The authors also reported good criterion and construct validity. The PHQ-9 was 152 validated against professional diagnoses of MDD, resulting in 88% sensitivity and 88% 153 specificity (at a PHQ-9 sum-score of ≥ 10); and scores correlated highly with similar constructs, 154 such as the 20-item Short-Form General Health Survey (SF-20) 25 mental health scale (r = .73). 155
Internal consistency of the PHQ-9 in the UK Biobank sample in the current study was high 156 (Cronbach's α = .83). 157
Depression Item Phenotypes 158
Each of the nine PHQ-9 items is considered a separate phenotype in the genetic analyses. 159
The ordinal scale of measurement of these items complicates interpretation of the SNP-based 160 heritability estimates (amount of phenotypic variance in the item explained by SNPs). SNP-161 based heritability is an important concept in genetics, essential to understanding the magnitude of 162 the genetic influence on a particular trait 26 . To enable a direct comparison across each of the 163 PHQ-9 items, each ordinal phenotype was transformed to a binary phenotype for heritability 164 estimation. The nine items were dichotomised such that an item was considered to be endorsed if 165 the item score was one or greater (several days, more than half the days, or nearly every day), 166
and not endorsed if the score was zero (not at all). A cut-off score of one was used in order to 167 maximise the number of subjects who endorsed an item and hence statistical power, a strategy 168 that has provided greater benefit in GWASs of depression over ensuring a seamless 169 phenotype 3, 11, 14, 27 . In addition to the nine ordinal items and nine binary items, a sum-score (sum 170 of all ordinal item scores; ranging from 0 to 27) and binary sum-score (number of binary items 171 endorsed; ranging from 0 to 9) were included as phenotypes. We will present the results from the 172 binary items and the two sum-scores while results for ordinal items are provided in 173
supplementary. 174
Genome-Wide Association Analyses 175
A total of 20 GWA analyses were conducted (nine ordinal scale depression items, nine 176 binary items, plus the sum-score and binary sum-score phenotypes) using BOLT-LMM 28 . 177
Associations between SNPs and a phenotype are tested using a linear mixed model in order to 178 correct for population structure and cryptic relatedness. While BOLT-LMM is based on a 179 quantitative trait model, it can be used to analyse binary traits by treating them as continuous and 180 applying a transformation. Ordinal items are treated as continuous. An issue when analysing 181 binary traits in BOLT-LMM is the inflated type 1 error rates for rare SNPs when the number of 182 cases and controls are very unbalanced 29 . In practice, all of the traits we consider here have a 183 case proportion which is large enough (3%) for this not to be a problem 30 . 184
Analyses were limited to autosomal SNPs with high imputation quality score (INFO 185 score ≥ 0.80) and a minor allele frequency of 1% or higher, resulting in 9,413,637 SNPs being 186 tested for association. Sex and age were included as covariates. GWAS results were annotated 187 using the FUMA GWAS platform 31 . The conventional genome-wide significance threshold of 188
−8 was applied. Due to the exploratory nature of the analyses and the high correlation 189 between the 20 phenotypes, we decided not to correct for multiple testing of the 20 phenotypes 190 as this would lead to increased type-II error rate and reduced power. 191
Significant SNPs were clumped into blocks high in linkage disequilibrium (the non-192 random association of alleles at a specific locus; LD) using a threshold of r 2 < 0.10 (correlation 193 between allele frequencies of two SNPs; as calculated by PLINK). Independent significant SNPs 194 were defined as the SNP with the lowest p-value within an LD block. Genomic risk loci (distinct, 195 fixed positions on a chromosome) were identified by merging independent SNPs if r 2 ≥ 0.10 and 196 their LD blocks are physically close to each other at a distance of 1,000 kb. 197
LDSC analyses 198
Estimates of the variance in each phenotype attributable to the additive effects of all 199 SNPs (SNP-based heritability; h 2 SNP) were calculated via single-trait LD Score Regression using 200 GWAS summary statistics from our analyses 32 (see Supplementary methods). In order to 201 interpret h 2 SNP for binary items estimates are converted to a normally distributed liability scale, 202 because liability scale heritability is independent of prevalence and can be compared across 203 different phenotypes and populations 33 . The population prevalence of PHQ-9 items was 204 estimated from our UK Biobank sample (population prevalence = sample prevalence; see Table  205 1). We applied a Bonferroni corrected significance threshold for the 11 h 2 SNP estimates (p < 206
Cross-trait LD Score Regression 34 was used to estimate genetic correlations (rg) between 208 each of the nine binary items. We applied a Bonferroni corrected significance threshold for these 209 36 rg tests (p < 1.39×10 −3 ). Additionally, we also calculated pairwise genetic correlations 210 between our phenotypes (9 depression items and sum-scores) and 25 other psychiatric, substance 211 use, socioeconomic and human traits with publicly available GWAS summary statistics (see 212
Supplementary 
Hierarchical Cluster Analysis 215
A hierarchical cluster analysis was conducted to examine the underlying genetic structure 216 between depression items. Implemented in the hclust function in R 35 , items are grouped into 217 similar clusters based on a measure of dissimilarity between each pair of items and the results are 218 presented in a cluster dendrogram. Dissimilarity was defined as one minus the genetic correlation 219
(1 -rg). 220
Confirmatory Factor Analyses 221
Confirmatory factor analyses (CFA) were conducted based on genetic covariances 222 between items, in order to quantitatively assess the genetic factor structure of the PHQ-9 223 identified in the cluster analysis. The fit of a one-factor baseline model and two and three-factor 224 models identified in the cluster analysis were compared. 225 2 likelihood ratio tests are very sensitive to large samples and often produce spurious 226 positive results 36 . Given the very large sample size in the present study, model fit was evaluated 227 with a range of alternative fit indices. These indices (and their commonly used thresholds for 228 acceptable model fit) include: NFI (≥ .95), AGFI (≥ .95), RMSEA (≤ .06), and SRMR (≤ .06) 37 . 229
Models were compared using AIC and BIC indices, which take into account both model fit and 230 complexity. The most parsimonious model is the model with the lowest AIC and BIC values. 231
Results

233
Descriptive Statistics 234
The final sample (N = 148,752) was 56% female, ranging in age from 38 to 72 years old 235 (M = 55.93, SD = 7.73). The distribution of responses to all PHQ-9 items (on the ordinal scale) 236 are displayed in Supplementary Table 3 . The distribution of item scores varied considerably 237 across items; sleep problems and fatigue had the highest endorsement rates while suicidal 238 ideation and psychomotor changes had the lowest rates. Sum-scores ranged from 0 to 27, with a 239 mean of 2.71 (SD = 3.61). Endorsement rates of binary depression items are shown in Table 1 . 240
The number of symptoms endorsed ranged from zero to nine, with a mean of 2.02 (SD = 2.20). 241
GWA Analyses 242
Genome-wide association analyses of the 9 binary depression items plus sum-score 243 phenotypes identified a total of 326 genome-wide significant SNPs (p < 5×10 −8 ), tagged by 13 244 independent SNPs. Two lead SNPs were significant in more than one phenotype, such that across 245 all phenotypes there are 11 unique, independent genome-wide significant SNPs. These SNPs 246 mapped onto nine genomic risk loci (see Table 2 for results, Supplementary Figures 1-10 
GWAS results). 249
Heritability Estimates 250
Estimates of the proportion of phenotypic variance in each item attributable to the 251 additive effects of all SNPs (SNP-based heritability; h 2 SNP) varied considerably across the nine 252 items (see Figure 1 and Supplementary Table 5 ). All estimates were significant after Bonferroni 253 correction (p < 4.55×10 −3 ). The amount of variance explained by common SNPs ranged from 3% 254 of variance in suicidal ideation up to 11% of the variance in fatigue (mean h 2 SNP across the nine 255 depression items was 7%). h 2 SNP estimates for the sum-score and no. symptoms phenotypes were 256 6% and 7%, respectively. 257
Inter-item Phenotypic and Genetic Correlations 258
Spearman correlations between all pairs of PHQ-9 depression items showed that all items 259
were positively correlated with each other phenotypically and remained significant after 260
Bonferroni correction for 36 tests (p < 1.39×10 −3 ). Coefficients ranged from .19 to .69, with the 261 strongest association between anhedonia and depressed mood, the two core symptoms of MDD 262 (see Figure 2) . 263
Summary statistics from the GWASs of the nine binary items were used to calculate 264 genetic correlations (rg) between items. All correlations were significant after correcting for 265 multiple testing (p < 1.39×10 −3 ) and were in the same direction (see Figure 2 ). Estimated rg's 266 was high, r = .90, p < .001 (see Supplementary Figure 11) . 276
The Pearson correlation between the genetic correlations and phenotypic correlations was 277 moderate, r = .48, p = .003, suggesting phenotypic correlations do not map one to one with 278 genetic correlations (see Supplementary Figure 12) . 279
Genetic Clustering Analysis 280
A hierarchical clustering analysis based on genetic covariance between the nine 281 depression items revealed two main genetic clusters: the first cluster including anhedonia, 282 depressed mood, suicidal ideation, and low self-esteem (psychological symptoms); and the 283 second cluster including psychomotor changes, concentration problems, fatigue, appetite change, 284 and sleep problems (somatic symptoms; see Figure 3 ). Further exploration of the cluster 285 dendrogram suggests the somatic symptoms cluster could again be split into two clusters: 286 "neurovegetative" symptoms (fatigue, appetite change, and sleep problems); and "psychomotor / 287 concentration" symptoms. 288
Confirmatory Factor Analyses 289
CFA of the genetic factor structure found that all three models provided good fit to the 290 data (see Supplementary Table 7) . Comparison of models based on AIC and BIC values found 291 that the three-factor model was the most parsimonious model compared to the one-factor model 292 and the two-factor model (substantially lower AIC and BIC values). These results suggest the 293 PHQ-9 is reflected genetically by three factors, comprising "psychological", "neurovegetative", 294
and "psychomotor / concentration" symptoms. 295
Genetic Correlations with External Traits 296
Genetic correlations of the nine depression items, sum-score and binary sum-score with 297 25 other psychiatric, substance use, socioeconomic and human traits are displayed in Figure 4 . 298 Correlations significant after correcting for false discovery rate (FDR) are indicated by non-299 white squares (see Supplementary Table 8 In the present study, we investigated genetic heterogeneity in major depression by 318 conducting genetic analyses on individual symptoms of MDD in 148,752 participants from the 319 UK Biobank. We identified nine genomic risk loci across the nine MDD symptoms and sum-320 score phenotypes, all have not been associated with major depression in previous 321
GWASs 3, 7, 13, 14, 27, [38] [39] [40] [41] [42] [43] . Our results revealed substantial genetic heterogeneity in depression 322 symptoms with no overlap in significant loci across PHQ items. Though we acknowledge that 323 the lack of overlap may be due to low statistical power to detect all true associations, we 324 highlight some notable examples where a specific symptom of depression is linked to a gene that 325 was previously found to be associated with a strongly related phenotype. For the item "sleep 326 problems", we found SNPs that implicate PAX8 (based on proximity), a transcription factor 327 related to thyroid follicular cell development and expression of thyroid-specific genes, 328 replicating previous studies linking this gene to sleep duration [44] [45] [46] . In addition, SNPs associated 329 with "depressed mood" influenced the expression of KLHDC8B (protein coding gene involved in 330 cytokinesis). This gene has been previously linked to depressed affect, a sub-cluster of 331 neuroticism that is strongly related to depression 47 . Neither of these genes were implicated in the 332 largest GWASs of overall depression 3, 14 , illustrating the importance of exploring genetic 333 associations for specific symptoms of depression. 334 SNP-based heritability analyses revealed that individual depression symptoms were 335 differentially heritable (h 2 SNP ranging from 3 to 11%), suggesting that depression symptoms 336 differ in their relative proportions of common SNP contributions. Notably, items within the 337 "neurovegetative" symptom cluster were most highly heritable, consistent with a previous report 338 that found somatic symptoms (such as sleep problems and appetite changes) to have a stronger 339 heritable basis 18 . 340
Genetic correlations between depression symptoms ranged from moderate (rg < .60) to 341 high (rg > .90), suggesting that while some symptoms have high genetic overlap, a substantial 342 amount of genetic variation is not shared between symptoms. This indicates extensive genetic 343 heterogeneity in major depression, in line with the finding that depression represents multiple 344 dimensions of genetic risk 19 and previous associations between individual symptoms and specific 345 polymorphisms 48 . 346
The underlying genetic structure between symptoms was best explained by three genetic 347
clusters. This suggests there are risk factors specific to clusters which could indicate underlying 348 biology specific to either "neurovegetative", "psychological" or "psychomotor / concentration" 349 symptoms of depression. This is consistent with symptoms differing in their biological 350 correlates, with neurovegetative symptoms such as weight gain, increased appetite, and sleep 351 problems being associated with higher levels of inflammation markers 49, 50 . These clusters were 352 not in full agreement with the three genetic factors found by Kendler, et al. 19 based on an 353 analysis of twin data. As an example, in the Kendler study, suicidal ideation loaded onto the 354 same factor as psychomotor changes and concentration problems, while we find that suicidal 355 ideation clusters with symptoms of depressed mood, anhedonia, and low self-esteem that 356 together form a "psychological symptoms" factor. However results are not easily comparable 357 given that they derived factors from a twin study (and therefore captured rare genetic variants as 358 well as common SNPs), used a subset of eight symptoms (appetite changes did not load onto any 359 factor), and symptom phenotypes came from structured clinical interview rather than a self-360 report measure such as the PHQ-9. 361
Results from genetic correlations between items and a range of external traits lead us to 362 note three general observations. First, genetic correlations with external traits differed 363 substantially between symptoms providing evidence for genetic heterogeneity in major 364 depression. In agreement with previous findings for major depression 3, 14 , all symptoms 365 overlapped with anxiety, schizophrenia, ADHD, insomnia, neuroticism, and subjective well-366 being, however the proportion of overlap varied considerably across symptoms. For example, 367 anxiety disorders had a substantially higher genetic correlation with "suicidal ideation" than the 368 other items. This supports a strong phenotypic association, with over 70% of people with a 369 history of suicide attempt having an anxiety disorder, compared to ~33% in the general 370 population 51 . Second, some traits (such as bipolar disorder, cannabis lifetime use, cigarettes per 371 day, and intelligence) were genetically correlated with a subset of items only. Bipolar disorder 372 for example, was genetically correlated with only four items (low self-esteem, concentration, 373 psychomotor changes, and sleep problems), suggesting that the moderate genetic overlap 374 between bipolar and major depression 52 is predominately driven by these selected symptoms. 375
This highlights how insight into the genetic architecture between traits can be gained from 376 conducting symptom-level analyses. Third, we found traits that were genetically correlated with 377 individual items, but not with the sum-score phenotypes. Anorexia nervosa did not overlap with 378 aggregate measures of depression symptoms as operationalized in the sum-score phenotypes, in 379 agreement with Howard, et al. 14 who similarly found no genetic overlap between anorexia and 380 their three overall depression phenotypes. Yet, anorexia nervosa was genetically correlated with 381 appetite change, low self-esteem, and psychomotor changes. Interestingly, the overlap with 382 appetite change was in the opposite direction compared to the other two items. This finding 383 emphasises the importance of analysing individual symptoms of a disorder, as important 384 information is ignored by relying on sum-scores or overall phenotypes. 385
Limitations 386
The findings and conclusions of this study should be interpreted in view of some key 387 limitations. First, despite having the largest sample available to date, the current study is still 388 underpowered to detect significant SNPs. Given the relatively high prevalence and phenotypic 389 heterogeneity of depression, much larger sample sizes are needed compared to other psychiatric 390 disorders 11 .
To not reduce power further we did not correct for multiple testing (of 11 GWA 391 analyses) and hence our GWAS results require independent replication. Second, depression items 392 were analysed in isolation, regardless of the overall MDD status of the participant. For example, 393 a participant could strongly endorse the symptom fatigue, yet have no other signs of depression 394 and hence the endorsement of fatigue is unrelated to major depression. Nevertheless, it is 395 possible that fatigue, regardless of the context it occurs in, possesses the same underlying genetic 396 basis. Third, we used a PHQ-9 cut-off score of 1 to dichotomise items in order to maximise the 397 number of cases and improve statistical power. A PHQ-9 item score of one does not meet the 398 diagnostic criteria for endorsement, hence the phenotypes may represent a predisposition to 399 rather than full endorsement of the particular symptom. Fourth, our results may be affected by 400 ascertainment bias due to healthy volunteerism within the UKBB. As such our sample could 401 represent a truncated version of the population's genetic distribution for symptoms (people on far 402 end of liability scale may be less likely to participate), hence resulting in reduced number of 403 cases for some symptoms or reduced variation between cases and controls. 404
Implications 405
The recent success in the discovery of genetic variants associated with depression has 406 been driven by ever increasing sample sizes, an approach that has been favoured over reducing 407 phenotypic heterogeneity. Consequently, GWASs have been conducted on a diverse range of 408 depression-related phenotypes that often include a small subset of symptoms, generally with the 409 view that the increase in sample size can overcome the lack of clinical precision. While this has 410 indeed been proven to be effective at increasing the number of significant variants identified, our 411 finding of symptom-level genetic heterogeneity raises questions about this approach. Using 412 broad diagnostic phenotypes ignores the unique genetic factors associated with specific 413 symptoms of depression that would likely provide useful information to further unravel the 414 genetic architecture of MDD. Further, our finding of genetic heterogeneity across MDD 415 symptoms implicates that patients with MDD show variation in disease pathogenesis. This 416 variation may be linked to response to clinical interventions, such that patients presenting with 417 specific symptom patterns (e.g., characterized primarily by neurovegetative symptoms) may be 418 expected to respond differently. 419
Conclusion 420
Our results provide convincing evidence that major depression is a genetically 421 heterogeneous disorder, and highlight the utility of analysing the genetics of individual items or 422 symptoms of a psychiatric disorder. Insights into the genetic aetiology and underlying biology of 423 MDD will be maximised by combining large-scale genetic studies of broad clinical definitions 424 with follow-up studies of more refined phenotypic measures of specific diagnostic subtypes. 54 . SNP rs137997194 and rs143756010 are tagging the same signal, but was the SNP with lowest p-value in "depressed mood" and "binary sum-score", respectively. Figure 1 . SNP-based heritability estimates and 95% confidence intervals (95% CI) for the nine depression items and sum-score phenotypes.
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Figures
Note: heritability estimated via single-trait LD Score Regression. The dotted line indicates the SNP-based heritability of major depression (h 2 SNP = ~0.09) 3 . All estimates are significant after multiple testing correction (p < 4.55×10 −3 ). Note: white squares indicate correlations that do not meet significance after correcting for FDR.
